Stay updated on Ferumoxytol MRI in Glioblastoma Response Clinical Trial

Sign up to get notified when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a new revision from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding-status notice about government operating status has been removed. Study details, eligibility criteria, and contacts remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:25.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Results have been posted with updated primary and secondary outcomes, and the study completion date has been revised. The page now reflects the current status and sponsor/collaborator details.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:28.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Major change: page now advertises a government operating status notice and updates the release version to v3.2.0; the previous v3.1.0 version tag was removed.
    Difference
    3%
    Check dated 2025-10-05T13:23:48.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T09:36:28.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now reflects termination and a PI transition, posted results, and a protocol update (v3.0.2) with a smaller sample size (52) and new survival/safety endpoints; older immunology endpoints were removed.
    Difference
    18%
    Check dated 2025-09-14T00:05:35.000Z thumbnail image

Stay in the know with updates to Ferumoxytol MRI in Glioblastoma Response Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ferumoxytol MRI in Glioblastoma Response Clinical Trial page.